Differentiating Hashimoto's thyroiditis from other diseases: Difference between revisions
Line 269: | Line 269: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Present | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Present | ||
| align="left" style="padding: 5px 5px; background: #F5F5F5;" | | | align="left" style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | * Patient may have opthalmopathy and dermopathy | ||
|- | |- | ||
| align="center" style="background:#DCDCDC;" |[[Toxic thyroid nodule]] | | align="center" style="background:#DCDCDC;" |[[Toxic thyroid nodule]] | ||
Line 282: | Line 282: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | ||
| align="left" style="padding: 5px 5px; background: #F5F5F5;" | | | align="left" style="padding: 5px 5px; background: #F5F5F5;" | | ||
- | |||
|- | |- | ||
| rowspan="1" style="background:#DCDCDC;" |[[Secondary hyperthyroidism]] | | rowspan="1" style="background:#DCDCDC;" |[[Secondary hyperthyroidism]] | ||
Line 296: | Line 296: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | ||
| align="left" style="padding: 5px 5px; background: #F5F5F5;" | | | align="left" style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | *Inappropriately normal or increased TSH | ||
|- | |- | ||
| rowspan="1" style="background:#DCDCDC;" |[[Tertiary hyperthyroidism]] | | rowspan="1" style="background:#DCDCDC;" |[[Tertiary hyperthyroidism]] | ||
Line 310: | Line 310: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | ||
| align="left" style="padding: 5px 5px; background: #F5F5F5;" | | | align="left" style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | *Inappropriately normal or increased TSH | ||
|- | |- | ||
| rowspan="2" style="background:#DCDCDC;" |Drug induced | | rowspan="2" style="background:#DCDCDC;" |Drug induced | ||
Line 324: | Line 324: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | ||
| align="left" style="padding: 5px 5px; background: #F5F5F5;" | | | align="left" style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | *High urinary iodine | ||
|- | |- | ||
| align="center" style="background:#DCDCDC;" |[[Amiodarone type 2]] | | align="center" style="background:#DCDCDC;" |[[Amiodarone type 2]] | ||
Line 337: | Line 337: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | ||
| align="left" style="padding: 5px 5px; background: #F5F5F5;" | | | align="left" style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | *High urinary iodine | ||
|- | |- | ||
| rowspan="3" style="background:#DCDCDC;" |Others | | rowspan="3" style="background:#DCDCDC;" |Others | ||
Line 351: | Line 351: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | ||
| align="left" style="padding: 5px 5px; background: #F5F5F5;" | | | align="left" style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | *Decreased thyroglobulin | ||
|- | |- | ||
| align="center" style="background:#DCDCDC;" |[[Trophoblastic disease]] | | align="center" style="background:#DCDCDC;" |[[Trophoblastic disease]] | ||
Line 364: | Line 364: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | ||
| align="left" style="padding: 5px 5px; background: #F5F5F5;" | | | align="left" style="padding: 5px 5px; background: #F5F5F5;" | | ||
- | |||
|- | |- | ||
| align="center" style="background:#DCDCDC;" |[[Struma Ovari]] | | align="center" style="background:#DCDCDC;" |[[Struma Ovari]] | ||
Line 377: | Line 377: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | ||
| align="left" style="padding: 5px 5px; background: #F5F5F5;" | | | align="left" style="padding: 5px 5px; background: #F5F5F5;" | | ||
- | |||
|- | |- | ||
|} | |} |
Revision as of 16:16, 5 October 2017
Hashimoto's thyroiditis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Differentiating Hashimoto's thyroiditis from other diseases On the Web |
American Roentgen Ray Society Images of Differentiating Hashimoto's thyroiditis from other diseases |
FDA on Differentiating Hashimoto's thyroiditis from other diseases |
CDC on Differentiating Hashimoto's thyroiditis from other diseases |
Differentiating Hashimoto's thyroiditis from other diseases in the news |
Blogs on Differentiating Hashimoto's thyroiditis from other diseases |
Risk calculators and risk factors for Differentiating Hashimoto's thyroiditis from other diseases |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Furqan M M. M.B.B.S[2]
Overview
Hashimoto's thyroiditis must be differentiated from other causes of thyroiditis, such as De Quervain's thyroiditis, Riedel's thyroiditis, and suppurative thyroiditis.
Differentiating Hashimoto's Thyroiditis from other Diseases
Differentiating Hashimoto's thyroiditis from other causes of thyroiditis
- Hashimoto's thyroiditis must be differentiated from other causes of thyroiditis, such as De Quervain's thyroiditis, Riedel's thyroiditis, and suppurative thyroiditis.[1]
Conditions | Causes | Age at onset | Pathological findings | Diagnostic approach |
---|---|---|---|---|
Hashimoto's thyroiditis |
|
|
|
|
Painful subacute (De Quervain's) thyroiditis |
|
|
|
|
Silent thyroiditis |
|
|
|
|
Postpartum thyroiditis |
|
|
|
|
Riedel's thyroiditis |
|
|
|
|
Suppurative thyroiditis |
|
|
|
|
Differentiating Hashimoto's thyroiditis from other causes of hypothyroidism
- Hashimoto's thyroiditis must be differentiated from other causes of hypothyroidism on the basis of history and symptoms and laboratory findings:[2][3][1][4][5][6]
Disease | History and symptoms | Laboratory findings | Additional findings | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Fever | Pain | TSH | Free T4 | T3 | T3RU† | Thyroglobin | TRH | TPOAb^ | |||
Primary hypothyroidism | Autoimmune (Hashimoto's thyroiditis) | - | - | ↑* | ↓ | Normal/↓ | Normal/↓ | Normal/↑ | Normal | Present (high titer) |
|
Riedel's thyroiditis | - | - | Normal/↑ | Normal/↓ | Normal/↓ | Normal/↓ | Normal | Normal | Usually present |
| |
Infectious thyroiditis | + | + | Normal | Normal | Normal | Normal | Normal | Normal | Absent |
| |
Transient hypothyroidism | Subacute (de Quervain's) thyroiditis | +/- | +/- | ↑/↓ | ↓/↑ | Normal | ↓ | ↑ | Normal | Low/absent |
|
Postpartum thyroiditis | +/- | +/- | ↑/↓ | ↓/↑ | Normal | ↓ | ↑ | Normal/↑ | Present (high titer) |
| |
Silent thyroiditis | - | - | ↑/↓ | ↓/↑ | Normal | ↓ | ↑ | Normal | Present (high titer) |
| |
Others | Drug-induced | - | - | ↑/↓ | ↓/↑ | Normal | ↓ | Normal/↑ | Normal | Absent** |
|
Radiation-induced | |||||||||||
Trauma induced | |||||||||||
Radioiodine induced | |||||||||||
Thyroidectomy | |||||||||||
Subclinical hypothyroidism | - | - | ↑ | Normal | Normal | Normal | Normal | Normal | Normal/↑ |
|
(†)T3RU; Triiodothyronine Resin uptake. (^)TPOAb; Thyroid peroxidase antibodies. (*)TSH may be decreased transiently in the thyrotoxicosis. (**)TPOAb may be present in drug-induced hypo/hyperthyroidism such as Interferon-alpha, interleukin-2, and lithium.
Differentiating Hashimoto's thyroiditis from other causes of thyrotoxicosis
Disease | History and symptoms | Laboratory findings | Additional findings | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Fever | Pain | TSH | Free T4 | T3 | T3RU† | Thyroglobin | TRH | TSH Receptor Antibody | |||
Primary hyperthyroidism | Grave's disease | - | - | ↓ | ↑ | Normal/↑ | ↑ | ↑ | Normal | Present |
|
Toxic thyroid nodule | - | - | ↓ | ↑ | Normal/↑ | ↑(hot nodule) | Normal/↑ | Normal | Absent |
- | |
Secondary hyperthyroidism | Pituitary adenoma | - | - | ↑ | ↑ | Normal/↑ | ↑ | Normal/↑ | Normal | Absent |
|
Tertiary hyperthyroidism | Tertiary hyperthyroidism | - | - | ↑ | ↑ | ↑ | ↑ | Normal/↑ | ↑ | Absent |
|
Drug induced | Amiodarone type 1 | - | - | ↓ | ↑ | Normal/↑ | ↓ | Normal/↑ | Normal | Absent |
|
Amiodarone type 2 | - | - | ↓ | ↑ | Normal/↑ | Absent/↓ | Normal/↑ | Normal | Absent |
| |
Others | Factitious thyrotoxicosis | - | - | ↓ | ↑ | Normal/↑ | ↓ | ↓ | Normal | Absent |
|
Trophoblastic disease | - | - | ↓ | ↑ | Normal/↑ | ↑ | - | Normal | Absent |
- | |
Struma Ovari | - | - | ↓ | ↑ | Normal/↑ | ↓ | - | Normal | Absent |
- |
Cause of thyrotoxicosis | TSH receptor antibodies | Thyroid US | Color flow Doppler | Radioactive iodine uptake/Scan | Other features |
---|---|---|---|---|---|
Graves' disease | + | Hypoechoic pattern | ↑ | ↑ | Ophthalmopathy, dermopathy, acropachy |
Toxic nodular goiter | - | Multiple nodules | - | Hot nodules at thyroid scan | - |
Toxic adenoma | - | Single nodule | - | Hot nodule | - |
Subacute thyroiditis | - | Heterogeneous hypoechoic areas | Reduced/absent flow | ↓ | Neck pain, fever, and elevated inflammatory index |
Painless thyroiditis | - | Hypoechoic pattern | Reduced/absent flow | ↓ | - |
Amiodarone induced thyroiditis-Type 1 | - | Diffuse or nodular goiter | ↓/Normal/↑ | ↓ but higher than in Type 2 | High urinary iodine |
Amiodarone induced thyroiditis-Type 2 | - | Normal | Absent | ↓/absent | High urinary iodine |
Central hyperthyroidism | - | Diffuse or nodular goiter | Normal/↑ | ↑ | Inappropriately normal or high TSH |
Trophoblastic disease | - | Diffuse or nodular goiter | Normal/↑ | ↑ | - |
Factitious thyrotoxicosis | - | Variable | Reduced/absent flow | ↓ | ↓ Serum thyroglobulin |
Struma ovarii | - | Variable | Reduced/absent flow | ↓ | Abdominal RAIU |
References
- ↑ 1.0 1.1 "Thyroiditis — NEJM".
- ↑ Bindra A, Braunstein GD (2006). "Thyroiditis". Am Fam Physician. 73 (10): 1769–76. PMID 16734054.
- ↑ McDermott MT (2009). "In the clinic. Hypothyroidism". Ann. Intern. Med. 151 (11): ITC61. doi:10.7326/0003-4819-151-11-200912010-01006. PMID 19949140.
- ↑ Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR (2007). "Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002)". Thyroid. 17 (12): 1211–23. doi:10.1089/thy.2006.0235. PMID 18177256.
- ↑ Lania A, Persani L, Beck-Peccoz P (2008). "Central hypothyroidism". Pituitary. 11 (2): 181–6. doi:10.1007/s11102-008-0122-6. PMID 18415684.
- ↑ De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, Stockigt J. "Clinical Strategies in the Testing of Thyroid Function". PMID 25905413.